BIOSTON Trademark

Trademark Overview


On Wednesday, September 14, 2016, a trademark application was filed for BIOSTON with the United States Patent and Trademark Office. The USPTO has given the BIOSTON trademark a serial number of 87171817. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 20, 2025. This trademark is owned by BiOStON Therapeutics, Inc.. The BIOSTON trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields; Research and development of advanced learning technologies and teaching methods; Research and development of new products; Research and development of new products for others; Research in the field of chemistry; Research on food; Research on the subject of pharmaceuticals; Agricultural research; Agrochemical research services; Bacteriological research; Bacteriological research and testing; Bacteriological consultation and research; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical research; Cosmetics research; Cosmetics research for others; Food research; Medical research services in the field of cancer; Medical and scientific research in the field of medical imaging; Medical and scientific research in the field of novel drugs; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical research and developme...
bioston

General Information


Serial Number87171817
Word MarkBIOSTON
Filing DateWednesday, September 14, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 20, 2025
Registration Number5623215
Registration DateTuesday, December 4, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 31, 2017

Trademark Statements


Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields; Research and development of advanced learning technologies and teaching methods; Research and development of new products; Research and development of new products for others; Research in the field of chemistry; Research on food; Research on the subject of pharmaceuticals; Agricultural research; Agrochemical research services; Bacteriological research; Bacteriological research and testing; Bacteriological consultation and research; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical research; Cosmetics research; Cosmetics research for others; Food research; Medical research services in the field of cancer; Medical and scientific research in the field of medical imaging; Medical and scientific research in the field of novel drugs; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical research and development; Pharmaceutical research services; Physics research; Product research; Product research and development; Providing medical research and scientific research information in the field of oncology via the Internet; Scientific research; Scientific research and development; Technical research in the field of pharmaceutical studies

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 20, 2025
Primary Code042
First Use Anywhere DateSaturday, October 1, 2016
First Use In Commerce DateSaturday, October 1, 2016

Trademark Owner History


Party NameINTODEWORLD, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBURLINGTON, MA 01803

Party NameBiOStON Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBURLINGTON, MA 01803

Party NameBiOStON Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBURLINGTON, MA 01803

Party NameBiOStON Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Saturday, September 17, 2016NEW APPLICATION ENTERED
Tuesday, January 31, 2017PUBLISHED FOR OPPOSITION
Friday, March 24, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 28, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 20, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 19, 2016ASSIGNED TO EXAMINER
Monday, December 19, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 11, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 31, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 26, 2017SOU EXTENSION 1 FILED
Tuesday, September 26, 2017SOU EXTENSION 1 GRANTED
Monday, April 9, 2018TEAS PETITION TO REVIVE RECEIVED
Monday, April 9, 2018PETITION TO REVIVE-GRANTED
Tuesday, April 10, 2018NOTICE OF REVIVAL - E-MAILED
Tuesday, September 26, 2017SOU TEAS EXTENSION RECEIVED
Thursday, September 28, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 28, 2018SOU EXTENSION 2 FILED
Monday, April 9, 2018SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, April 24, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 26, 2018SOU EXTENSION 2 GRANTED
Wednesday, September 26, 2018USE AMENDMENT FILED
Friday, September 28, 2018STATEMENT OF USE PROCESSING COMPLETE
Friday, November 2, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 4, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, March 11, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, December 4, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, June 20, 2025CANCELLED SEC. 8 (6-YR)
Thursday, November 1, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, April 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 16, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 26, 2018TEAS STATEMENT OF USE RECEIVED